Multimodality Imaging and Functional Lesion Assessment in Intermediate Coronary Stenosis in Chronic Coronary Syndrome
MultiInter-CCS
1 other identifier
observational
200
1 country
1
Brief Summary
The aim of this prospective, investigator-initiated study is to evaluate the diagnostic accuracy and correlations between functional indices (fractional flow reserve, FFR) and morphometric indices: luminal and qualitative parameters assessed by optical coherence tomography (OCT) including minimal lumen area, plaque type, presence of thin cap fibroatheroma among patients with chronic coronary syndrome identified with intermediate grade coronary stenosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 7, 2011
CompletedFirst Submitted
Initial submission to the registry
February 7, 2024
CompletedFirst Posted
Study publicly available on registry
February 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
ExpectedFebruary 15, 2024
February 1, 2024
13.7 years
February 7, 2024
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Correlation between fractional flow reserve (FFR) and minimal lumen area within the coronary stenosis
Baseline
Correlation between fractional flow reserve (FFR) and mean lumen area within the coronary stenosis
Baseline
Secondary Outcomes (1)
Major adverse cardiovascular events
36 months
Study Arms (1)
Patients with chronic coronary syndromes identified with intermediate grade coronary stenosis
Patients chronic coronary syndrome identified with intermediate grade coronary stenosis undergo coronary angiography according to current practice and guidelines recommendations. FFR will be measured, in consistency with the guidelines and recommended clinical practice. In case of FFR \> 0.8 optimal pharmacotherapy will be prescribed; on the contrary, in case of FFR ≤ 0.8 PCI will be performed. OCT imaging will be performed with commercially available device (Abbott, C7XR Dragonfly TM LightLab Imaging Inc., MA, USA) using the non-occlusive flushing technique.
Eligibility Criteria
Patients undergoing coronary angiogram due to chronic coronary syndrome with intermediate grade coronary stenosis.
You may qualify if:
- years or older
- Chronic coronary syndrome defined as presence of chest pain ranked 2-3 in the Canadian Cardiovascular Society classification or positive ischemia test (exercise test, single photon emission tomography (SPECT)
- Intermediate grade coronary stenosis of 40-80% assessed visually in coronary angiography
- FFR and OCT examination of the same lesion
- The patient is willing to participate in the study and has provided a written informed consent
You may not qualify if:
- Acute coronary syndrome
- Proximal left main lesion
- Ostial right coronary artery lesion
- Bypass of the assessed vessel
- Contraindications for adenosine administration
- Hemodynamic instability
- Heart insufficiency in New York Heart Association (NYHA) class IV scale
- Acute renal insufficiency
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Warsaw
Warsaw, Poland
Study Officials
- PRINCIPAL INVESTIGATOR
Mariusz Tomaniak, MD, PhD, Assoc. Prof.
Medical University of Warsaw
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, FESC
Study Record Dates
First Submitted
February 7, 2024
First Posted
February 15, 2024
Study Start
April 7, 2011
Primary Completion
December 31, 2024
Study Completion (Estimated)
December 31, 2028
Last Updated
February 15, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share